The classic website will no longer be available as of June 25, 2024. Please use the modernized

Key Record Dates Identifier: NCT05010772
Brief Title: Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission

First Submitted : August 11, 2021
First Submitted that Met QC Criteria : August 11, 2021
First Posted : August 18, 2021

Last Update Submitted that Met QC Criteria : June 5, 2024
Last Update Posted : June 6, 2024